Athyrium Capital Management LP logo

Athyrium Capital Management LP

North America, New York, United States, New York

Description

Athyrium Capital Management is a specialized asset management company focusing on investment opportunities in the global healthcare sector.

Investor Profile

Athyrium Capital Management LP has made 44 investments, with 1 in the past 12 months and 61% as lead.

Stage Focus

  • Post Ipo Debt (39%)
  • Private Equity (16%)
  • Post Ipo Equity (14%)
  • Debt Financing (14%)
  • Series B (7%)
  • Series Unknown (7%)
  • Series A (5%)

Country Focus

  • United States (80%)
  • Denmark (5%)
  • Ireland (2%)
  • Sweden (2%)
  • Switzerland (2%)
  • The Netherlands (2%)
  • France (2%)
  • Norway (2%)
  • United Kingdom (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Hospital
  • Life Science
  • Manufacturing
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Athyrium Capital Management LP frequently co-invest with?

First Round Capital
North America, California, United States, San Francisco
Co-Investments: 2
DeNovo Ventures
North America, California, United States, Saratoga
Co-Investments: 1
Amati Global Investors
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Technology Venture Partners
Oceania, New South Wales, Australia, Pyrmont
Co-Investments: 1
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 1
Aquilo Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
AMOREPACIFIC Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
HealthCare Royalty Partners
North America, Connecticut, United States, Stamford
Co-Investments: 2
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does Athyrium Capital Management LP often collaborate with?

AH
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by Athyrium Capital Management LP?

Esperion

Ann Arbor, Michigan, United States

Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo DebtDec 13, 2024
Amount Raised: $250,000,000
Vytyl Health Management

New Haven, Connecticut, United States

Vytyl Health Management delivers quality mental health care to adolescents and transitional age youth.

Health CareMental HealthPersonal HealthWellness
Series AJan 9, 2024
Amount Raised: $22,500,000
Calliditas Therapeutics

Stockholm, Stockholms Lan, Sweden

Calliditas Therapeutics is a specialty pharmaceutical company that develops pharmaceutical products in fields of unmet medical needs.

BiotechnologyMedical DevicePharmaceutical
Post Ipo DebtDec 27, 2023
Amount Raised: $102,197,808
Basilea Pharmaceutica

Basel, Basel-Stadt, Switzerland

Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.

BiotechnologyCommercialPharmaceutical
Post Ipo DebtSep 7, 2022
Amount Raised: $76,787,223
uMotif

London, England, United Kingdom

UMotif is a scalable and engaging patient-centred data capture platform for modern research.

Data VisualizationHealth CareInformation ServicesMarket ResearchMedicalSoftware
Series BMay 25, 2022
Amount Raised: $25,172,241
Revance Therapeutics

Newark, California, United States

Revance Therapeutics develops and commercializes products and treatments for dermatological diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo DebtMar 21, 2022
Amount Raised: $300,000,000
Puma Biotechnology

Los Angeles, California, United States

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

BiotechnologyMedicalTherapeutics
Post Ipo EquityMar 10, 2022
Amount Raised: $10,000,000
Osmotica Pharmaceutical

Marietta, Georgia, United States

Osmotica Pharmaceutical is a global specialty pharmaceutical company.

BiotechnologyPharmaceutical
Post Ipo DebtOct 7, 2021
Amount Raised: $100,000,000
Puma Biotechnology

Los Angeles, California, United States

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

BiotechnologyMedicalTherapeutics
Post Ipo DebtJul 26, 2021
Amount Raised: $125,000,000
Amryt Pharma

Dublin, Dublin, Ireland

Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.

BiopharmaLife ScienceMedicalPharmaceutical
Post Ipo EquityDec 8, 2020
Amount Raised: $40,000,000